Patent Assignment
Reel/Frame 067656/0848
Assignment of Assignor's Interest
Recorded: 2024-06-07
Pages: 9
Assignee
CAMBREX HIGH POINT, INC.
4180 MENDENHALL OAKS PARKWAY, HIGH POINT, NORTH CAROLINA, 27265
Covered Properties
(2)
Salts and Esters of APX3330 and Therapeutic Uses Thereof
Salts and Esters of APX3330 and Therapeutic Uses Thereof
Related Assignments
(8)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 7, 2024
From: CAMBREX HIGH POINT, INC.
To: OCUPHIRE PHARMA, INC.
Reel/Frame 067657/0131 →
Assignment of Assignor's Interest
Jun 7, 2024
From: ONICIU, DANIELA CARMEN
To: OCUPHIRE PHARMA, INC.
Reel/Frame 067655/0821 →
Assignment of Assignor's Interest
Jun 7, 2024
From: LUNGAN, MARIA-ANDREEA; PATRASCU, ANDREI-ALUNEL; MANTA, CORINA-MIHAELA
To: SARA PHARM SOLUTIONS S.R.L.
Reel/Frame 067655/0981 →
Assignment of Assignor's Interest
Jun 7, 2024
From: SARA PHARM SOLUTIONS S.R.L.
To: OCUPHIRE PHARMA, INC.
Reel/Frame 067656/0199 →
Change of Name
Jan 22, 2025
From: OCUPHIRE PHARMA, INC.
To: OPUS GENETICS, INC.
Reel/Frame 069987/0040 →
Change of Name
Mar 13, 2025
From: OCUPHIRE PHARMA, INC.
To: OPUS GENETICS, INC.
Reel/Frame 070514/0302 →
Security Interest
Apr 21, 2026
From: OPUS GENETICS, INC.
To: OPCM SA LLC, AS PURCHASER AGENT FOR THE SECURED PARTIES
Reel/Frame 075478/0138 →
Assignment of Assignor's Interest
Aug 5, 2026
From: OPUS GENETICS, INC.
To: APEXIAN PHARMACEUTICALS, INC.
Reel/Frame 075531/0886 →